A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease - Related Studies

A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease

This study has been completed.

Study NCT00035074. Last updated on June 23, 2005. Information provided by National Center for Research Resources (NCRR)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Inflammatory Bowel Disease

2	Additional conditions recognized in this trial
		Inflammatory Bowel Diseases
		Intestinal Diseases

3	More general conditions related to this trial
		Digestive System Diseases
		Gastroenteritis
		Gastrointestinal Diseases

4	Interventions listed in this trial
		Methotrexate

5	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Center for Research Resources (NCRR)
		Crohn's and Colitis Foundation